ACE and type 1 diabetes mellitus: We hypothesized that advances in the management of type 1 diabetes since the early 1980s (eg, modern CSII, insulin analogues, aggressive blood pressure management and ACE inhibitor prescribing) and specific features of intensification relating to flash monitor use may have reduced the risk of early worsening of eye disease following HbA1c reduction.